![]() Notably, they point to there being “no prospective, double-blind, randomized, controlled trials comparing digital aripiprazole with the non-digital version, other active comparators, or placebo.” (2019) describe the research and proposed applications underlying the FDA approval of the first of such digital pills-a form of aripiprazole (trade name Abilify)-to be misguided, at best. In an earlier published review article, however, Cosgrove et al. Those who manufacture and market these pills claim this is intended to help individuals remember to take their medication consistently and on time while making them more accountable to their doctors. ![]() With each pill equipped with its own digital sensor that detects when it has been consumed, data can be collected related to whether, and if so when, the medication was taken.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |